Clinical Trial Update: Cervical Rippening With Antiprogesterone in Midtrimester Abortions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating antiprogesterone (mifepristone) for cervical ripening in midtrimester abortions; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Missed Abortion

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Abortion, Missed | Phase 4 | Status: COMPLETED